DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us

News


Search news :

TRG Research Bulletin 16 - 2014

27-Oct-2014
News Image The fourth edition of the 2014 TRG newsletter is now available. Click the link below to find out about our work and recent activities:

[View the PDF]

Highly influential biomedical researchers (Scopus 1996-2011)

28-Aug-2014
News Image Professor Rury Holman has been identified as one of the top-400 living core biomedical researchers, based on a normalized score combining total citations and h-index, in a paper published in the European Journal of Clinical Investigation. In total, 8 University of Oxford biomedical researchers are listed.

[Link]

DTU Director gives plenary lecture at the 2014 Australian Diabetes Society Annual Scientific Meeting

28-Aug-2014
News Image Professor Rury Holman gave an invited lecture at the Australian Diabetes Society Annual Scientific Meeting on Wednesday 27th August 2014 which was attended by over 1,900 delegates.

His talk, entitled "How can we Reduce Residual Cardiovascular Risk in T2DM?", outlined five possible approaches to reducing the gap between the elevated cardiovascular risk seen even in well-treated people with diabetes and their non-diabetic peers.

[Link]

The world's leading scientific minds

02-Aug-2014
News Image Thomson Reuters report, "The world's most influential scientific minds: 2014", lists 3,200 individuals across 21 fields who have published the highest-impact work that is most frequently acknowledged by their peers. These papers rank in the top 1% by citation for their field and year of publication....

[Read more...]

TRG Research Bulletin 15 - 2014

01-Aug-2014
News Image The third edition of the 2014 TRG newsletter is now available. Click the link below to find out about our work and recent activities:

[View the PDF]

Royal College of Physicians debate

09-Jun-2014
News Image A meeting entitled "Update in diabetes: new drugs, new technology, new models of care" was held by the Royal College of Physicians (London) on Thursday 5th June 2014.

This included the debate: "Sulfonylureas should not be used routinely as second line treatments for patients with Type 2 Diabetes"

For: Dr Robert Ryder, Sandwell and West Birmingham Hospitals NHS Trust
Against: Professor Rury Holman, University of Oxford

The motion was defeated.

2014 Oxford BRC Open Day

26-May-2014
News Image The 2014 Oxford Biomedical Research Centre annual open day was held on Monday May 19, with teams demonstrating the latest technology and techniques tackling conditions such as cancer, dementia, arthritis and diabetes.

Staff from the Diabetes Trials Unit (DTU) Translational Research Group (TRG) were on hand to provide advice and insights into diabetes and the metbolic impact of different foods....

[Read more...]

DTU Clinician gives invited memorial lecture

14-May-2014
News Image On Friday 9 May, DTU Clinical Researcher Dr Matthew Wintle gave the invited Bill Williams Memorial Lecture at the Spring Meeting of the Society of Physicians in Wales. Around 60 clinicians who manage and deliver general medicine and speciality clinical services in hospitals across Wales travelled to the beautiful village of Portmeirion for the meeting....

[Read more...]

DTU Clinician attains highest level of membership of the Royal College of Physicians

13-May-2014
Congratulations to DTU Senior Clinical Researcher Dr Michael Theodorakis, who has become a Fellow of the Royal College of Physicians (FRCP), the highest level of membership awarded by the College.

Michael joined the DTU in July 2012, and is the Clinical Lead for the Acarbose Cardiovascular Evaluation (ACE) trial....

[Read more...]

TRG Research Bulletin 14 - 2014

22-Apr-2014
News Image The second edition of the 2014 TRG newsletter is now available. Click the link below to find out about our work and recent activities:

[View the PDF]

Researchers believe heart failure risks of glucose-lowering drugs are being overlooked in clinical trials

13-Mar-2014
News Image In a personal view article published online today in the journal The Lancet Diabetes & Endocrinology, researchers are calling for the systematic evaluation of heart failure to be included routinely in clinical outcome trials of glucose-lowering drugs.

Lead author Prof John McMurray of the University of Glasgow, together with DTU Director Prof Rury Holman and colleagues from Canada and the USA, are concerned that heart failure is rarely considered as a key outcome, or even part of composite cardiovascular outcomes, in large-scale clinical trials of glucose-lowering drugs....

[Read more...]

DTU Clinician wins Oxford College scholarship

07-Mar-2014
News Image Congratulations to our senior clinical researcher Dr Jyothis George, who has been appointed as a Robert Turner Research Associate until December 2014 at Green Templeton College (GTC), University of Oxford.

Jyothis is a Clinical Lead for one of our international mega trials, EXSCEL (EXenatide Study of Cardiovascular Event Lowering), works on early phase studies with the DTU Translational Research Group, and is a diabetologist in OCDEM....

[Read more...]

DTU Director gives special invited lecture in Taipei

05-Mar-2014
News Image Professor Rury Holman gave a special invited lecture at the 35th annual meeting of the Diabetes Association and the Endocrinology Society of the Republic Of China (Taiwan) on Sunday 2nd March 2014. Over 900 endocrinologists attended the meeting in Taipei....

[Read more...]

DTU appoints new Clinical Researcher

05-Mar-2014
News Image We are delighted to announce that Dr Matthew Wintle has joined the Diabetes Trials Unit (DTU) as a Clinical Researcher.

Matthew has joined us from Amylin Pharmaceuticals in California, where he was Global Medical Director....

[Read more...]

New software version of HOMA2 model released

20-Feb-2014
News Image Today we release the latest software version of our HOMA2 Calculator, which enables researchers to quickly assess the level of insulin resistance and how well beta cells are working in people with diabetes.

This new update (version 2.2.3) means the software can now support Mac OS X Lion or later....

[Read more...]

OCDEM event brings together Oxford researchers and industry to encourage new research collaborations

06-Feb-2014
News Image On 23rd January 2014, DTU Director Professor Rury Holman led an OCDEM Industry Networking Event to showcase translational diabetes research in Oxford and bring leading academics and R&D companies together to foster new collaborations.

Nearly 40 attendees, including Oxford basic science, translational and clinical researchers and representatives from national and international life sciences companies (including pharma, med tech and biotech) came together to hear about some of the exciting diabetes research programmes being undertaken in OCDEM, before moving to Oriel College for a drinks reception and networking dinner....

[Read more...]

DTU takes part in 2014's OCDEM Day

27-Jan-2014
DTU Director Prof Rury Holman gave the plenary talk at this year's OCDEM day, held on Friday 24th January.

Entitled "Putting the UK Prospective Diabetes Study into perspective", Prof Holman showed how, 15 years since its initial publication, this ground-breaking study is still as relevant to the diabetes community as it ever was....

[Read more...]

TRG Research Bulletin 13 - 2014

21-Jan-2014
News Image The first edition of the 2014 TRG newsletter is now available. Click the link below to find out about our work and recent activities:

[Link]